Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 172018, 7 pages
http://dx.doi.org/10.1155/2015/172018
Review Article

Could α-Synuclein Amyloid-Like Aggregates Trigger a Prionic Neuronal Invasion?

Department of Physical Chemistry, Faculty of Pharmacy, University of Barcelona, and Institute of Nanoscience and Nanotechnology of the University of Barcelona (IN2UB), Avenue Joan XXIII 27-31, Barcelona, 08028 Catalonia, Spain

Received 22 May 2014; Accepted 18 July 2014

Academic Editor: Beom S. Jeon

Copyright © 2015 Maria Antònia Busquets et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Aarsland and M. W. Kurz, “The epidemiology of dementia associated with parkinson's disease,” Brain Pathology, vol. 20, no. 3, pp. 633–639, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Maries, B. Dass, T. J. Collier, J. H. Kordower, and K. Steece-Collier, “The role of α-synuclein in Parkinson's disease: insights from animal models,” Nature Reviews Neuroscience, vol. 4, no. 9, pp. 727–738, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Masliah, E. Rockenstein, I. Veinbergs et al., “Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders,” Science, vol. 287, no. 5456, pp. 1265–1269, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. H. A. Lashuel, D. Hartley, B. M. Petre, T. Walz, and P. T. Lansbury Jr., “Neurodegenerative disease: amyloid pores from pathogenic mutations,” Nature, vol. 418, no. 6895, p. 291, 2002. View at Google Scholar · View at Scopus
  5. N. Carulla, G. L. Caddy, D. R. Hall et al., “Molecular recycling within amyloid fibrils,” Nature, vol. 436, no. 7050, pp. 554–558, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Kodali and R. Wetzel, “Polymorphism in the intermediates and products of amyloid assembly,” Current Opinion in Structural Biology, vol. 17, no. 1, pp. 48–57, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Chiti and C. M. Dobson, “Protein misfolding, functional amyloid, and human disease,” Annual Review of Biochemistry, vol. 75, pp. 333–366, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. E. C. Freundt, N. Maynard, E. K. Clancy et al., “Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport,” Annals of Neurology, vol. 72, no. 4, pp. 517–524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Soto, “Transmissible proteins: expanding the prion heresy,” Cell, vol. 149, no. 5, pp. 968–977, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Sabate, “When amyloids become prions,” Prion, vol. 8, no. 3, 2014. View at Google Scholar
  11. J. Narkiewicz, G. Giachin, and G. Legname, “In vitro aggregation assays for the characterization of alpha-synuclein prion-like properties,” Prion, vol. 8, no. 1, pp. 19–32, 2014. View at Google Scholar
  12. A. L. Fink, “The aggregation and fibrillation of α-synuclein,” Accounts of Chemical Research, vol. 39, no. 9, pp. 628–634, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. M. Morris and R. G. Finke, “α-Synuclein aggregation variable temperature and variable pH kinetic data: a re-analysis using the Finke-Watzky 2-step model of nucleation and autocatalytic growth,” Biophysical Chemistry, vol. 140, no. 1–3, pp. 9–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Giehm, N. Lorenzen, and D. E. Otzen, “Assays for α-synuclein aggregation,” Methods, vol. 53, no. 3, pp. 295–305, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Yonetani, T. Nonaka, M. Masuda et al., “Conversion of wild-type α-synuclein into mutant-type fibrils and its propagation in the presence of A30P mutant,” The Journal of Biological Chemistry, vol. 284, no. 12, pp. 7940–7950, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Bousset, L. Pieri, G. Ruiz-Arlandis et al., “Structural and functional characterization of two alpha-synuclein strains,” Nature Communications, vol. 4, article 2575, 2013. View at Publisher · View at Google Scholar
  17. M. Masuda-Suzukake, T. Nonaka, M. Hosokawa et al., “Prion-like spreading of pathological α-synuclein in brain,” Brain, vol. 136, no. 4, pp. 1128–1138, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Desplats, H. Lee, E. Bae et al., “Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 31, pp. 13010–13015, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Hansen, E. Angot, A. Bergström et al., “Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells,” Journal of Clinical Investigation, vol. 121, no. 2, pp. 715–725, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. L. A. Volpicelli-Daley, K. C. Luk, T. P. Patel et al., “Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death,” Neuron, vol. 72, no. 1, pp. 57–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Guo and V. M. Lee, “Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases,” Nature Medicine, vol. 20, no. 2, pp. 130–138, 2014. View at Google Scholar
  22. R. Nelson, M. R. Sawaya, M. Balbirnie et al., “Structure of the cross-β spine of amyloid-like fibrils,” Nature, vol. 435, no. 7043, pp. 773–778, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. K. C. Luk, C. Song, P. O'Brien et al., “Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 47, pp. 20051–20056, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Nonaka, S. T. Watanabe, T. Iwatsubo, and M. Hasegawa, “Seeded aggregation and toxicity of α-synuclein and tau: cellular models of neurodegenerative diseases,” The Journal of Biological Chemistry, vol. 285, no. 45, pp. 34885–34898, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. K. C. Luk, V. Kehm, J. Carroll et al., “Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice,” Science, vol. 338, no. 6109, pp. 949–953, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. K. C. Luk, V. M. Kehm, B. Zhang, P. O'Brien, J. Q. Trojanowski, and V. M. Y. Lee, “Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice,” Journal of Experimental Medicine, vol. 209, no. 5, pp. 975–988, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Mougenot, S. Nicot, A. Bencsik et al., “Prion-like acceleration of a synucleinopathy in a transgenic mouse model,” Neurobiology of Aging, vol. 33, no. 9, pp. 2225–2228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Emmanouilidou, K. Melachroinou, T. Roumeliotis et al., “Cell-produced α-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival,” Journal of Neuroscience, vol. 30, no. 20, pp. 6838–6851, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. F. Reyes, N. L. Rey, L. Bousset, R. Melki, P. Brundin, and E. Angot, “Alpha-synuclein transfers from neurons to oligodendrocytes,” Glia, vol. 62, no. 3, pp. 387–398, 2014. View at Google Scholar
  30. H. J. Lee, J. E. Suk, C. Patrick et al., “Direct transfer of α-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies,” The Journal of Biological Chemistry, vol. 285, no. 12, pp. 9262–9272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. H. Kordower, Y. Chu, R. A. Hauser, T. B. Freeman, and C. W. Olanow, “Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease,” Nature Medicine, vol. 14, no. 5, pp. 504–506, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. J. H. Kordower, Y. Chu, R. A. Hauser, C. W. Olanow, and T. B. Freeman, “Transplanted dopaminergic neurons develop PD pathologic changes: a second case report,” Movement Disorders, vol. 23, no. 16, pp. 2303–2306, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Kurowska, E. Englund, H. Widner, O. Lindvall, J. Li, and P. Brundin, “Signs of degeneration in 12–22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease,” Journal of Parkinsonαs Disease, vol. 1, no. 1, pp. 83–92, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Li, E. Englund, J. L. Holton et al., “Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation,” Nature Medicine, vol. 14, no. 5, pp. 501–503, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. N. P. Visanji, P. L. Brooks, L. N. Hazrati, and A. E. Lang, “The prion hypothesis in Parkinson's disease: braak to the future,” Acta Neuropathologica Communications, vol. 1, no. 1, p. 2, 2013. View at Publisher · View at Google Scholar
  36. C. Kim, D. Ho, J. Suk et al., “Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia,” Nature Communications, vol. 4, article 1562, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Demeester, G. Baier, C. Enzinger et al., “Apoptosis induced in neuronal cells by C-terminal amyloid β-fragments is correlated with their aggregation properties in phospholipid membranes,” Molecular Membrane Biology, vol. 17, no. 4, pp. 219–228, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Kawahara, Y. Kuroda, N. Arispe, and E. Rojas, “Alzheimer's β-amyloid, human islet amylin, and priori protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line,” The Journal of Biological Chemistry, vol. 275, no. 19, pp. 14077–14083, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Lin, R. Bhatia, and R. Lal, “Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology,” The FASEB Journal, vol. 15, no. 13, pp. 2433–2444, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Sabaté, A. Espargaró, L. Barbosa-Barros, S. Ventura, and J. Estelrich, “Effect of the surface charge of artificial model membranes on the aggregation of amyloid β-peptide,” Biochimie, vol. 94, no. 8, pp. 1730–1738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Aguzzi and A. M. Calella, “Prions: protein aggregation and infectious diseases,” Physiological Reviews, vol. 89, no. 4, pp. 1105–1152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. D. P. Karpinar, M. B. G. Balija, S. Kügler et al., “Pre-fibrillar alpha-synuclein variants with impaired Β-structure increase neurotoxicity in parkinson's disease models,” The EMBO Journal, vol. 28, no. 20, pp. 3256–3268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Taschenberger, M. Garrido, Y. Tereshchenko, M. Bähr, M. Zweckstetter, and S. Kügler, “Aggregation of αsynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons,” Acta Neuropathologica, vol. 123, no. 5, pp. 671–683, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Roostaee, S. Beaudoin, A. Staskevicius, and X. Roucou, “Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization,” Molecular Neurodegeneration, vol. 8, article 5, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Periquet, T. Fulga, L. Myllykangas, M. G. Schlossmacher, and M. B. Feany, “Aggregated α-synuclein mediates dopaminergic neurotoxicity in vivo,” The Journal of Neuroscience, vol. 27, no. 12, pp. 3338–3346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. T. F. Outeiro, P. Putcha, J. E. Tetzlaff et al., “Formation of toxic oligomeric α-synuclein species in living cells,” PLoS ONE, vol. 3, no. 4, Article ID e1867, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Zhou, G. Ottenberg, G. F. Sferrazza, and C. I. Lasmeźas, “Highly neurotoxic monomeric α-helical prion protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 8, pp. 3113–3118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. M. J. Volles and P. T. Lansbury Jr., “Relationships between the sequence of α-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity,” Journal of Molecular Biology, vol. 366, no. 5, pp. 1510–1522, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. P. K. Auluck, G. Caraveo, and S. Lindquist, “α-synuclein: membrane interactions and toxicity in parkinson's disease,” Annual Review of Cell and Developmental Biology, vol. 26, pp. 211–233, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Vamvaca, M. J. Volles, and P. T. Lansbury Jr., “he first N-terminal amino acids of α-synuclein are essential for alpha-helical structure formation in vitro and membrane binding in yeast,” Journal of Molecular Biology, vol. 389, no. 2, pp. 413–424, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. B. D. van Rooijen, M. M. A. E. Claessens, and V. Subramaniam, “Lipid bilayer disruption by oligomeric α-synuclein depends on bilayer charge and accessibility of the hydrophobic core,” Biochimica et Biophysica Acta, vol. 1788, no. 6, pp. 1271–1278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. H. A. Lashuel, B. M. Petre, J. Wall et al., “α-synuclein, especially the parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils,” Journal of Molecular Biology, vol. 322, no. 5, pp. 1089–1102, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Malato, S. Dos Reis, L. Benkemoun, R. Sabaté, and S. J. Saupe, “Role of Hsp104 in the propagation and inheritance of the [Het-s] prion,” Molecular Biology of the Cell, vol. 18, no. 12, pp. 4803–4812, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Tanaka, S. R. Collins, B. H. Toyama, and J. S. Weissman, “The physical basis of how prion conformations determine strain phenotypes,” Nature, vol. 442, no. 7102, pp. 585–589, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. K. M. Danzer, S. K. Krebs, M. Wolff, G. Birk, and B. Hengerer, “Seeding induced by α-synuclein oligomers provides evidence for spreading of α-synuclein pathology,” Journal of Neurochemistry, vol. 111, no. 1, pp. 192–203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Cappai, S. L. Leek, D. J. Tew et al., “Dopamine promotes α-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway,” The FASEB Journal, vol. 19, no. 10, pp. 1377–1379, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. V. N. Uversky, J. Li, and A. L. Fink, “Evidence for a partially folded intermediate in α-synuclein fibril formation,” The Journal of Biological Chemistry, vol. 276, no. 14, pp. 10737–10744, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Klucken, T. F. Outeiro, P. Nguyen, P. J. McLean, and B. T. Hyman, “Detection of novel intracellular α-synuclein oligomeric species by fluorescence lifetime imaging,” The FASEB Journal, vol. 20, no. 12, pp. 2050–2057, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. W. Ariesandi, C. Chang, T. Chen, and Y. Chen, “Temperature-dependent structural changes of Parkinson's alpha-synuclein reveal the role of pre-existing oligomers in alpha-synuclein fibrillization,” PLoS ONE, vol. 8, no. 1, Article ID e53487, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Dusa, J. Kaylor, S. Edridge, N. Bodner, D. Hong, and A. L. Fink, “Characterization of oligomers during α-synuclein aggregation using intrinsic tryptophan fluorescence,” Biochemistry, vol. 45, no. 8, pp. 2752–2760, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. N. Lorenzen, S. B. Nielsen, A. K. Buell et al., “The role of stable alpha-synuclein oligomers in the molecular events underlying amyloid formation,” Journal of the American Chemical Society, vol. 136, no. 10, pp. 3859–3868, 2014. View at Google Scholar
  62. R. Kayed, E. Head, J. L. Thompson et al., “Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis,” Science, vol. 300, no. 5618, pp. 486–489, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. H. A. Lashuel, C. R. Overk, A. Oueslati, and E. Masliah, “The many faces of α-synuclein: from structure and toxicity to therapeutic target,” Nature Reviews Neuroscience, vol. 14, no. 1, pp. 38–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Winner, R. Jappelli, S. K. Maji et al., “In vivo demonstration that α-synuclein oligomers are toxic,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 10, pp. 4194–4199, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. K. M. Danzer, D. Haasen, A. R. Karow et al., “Different species of alpha-synuclein oligomers induce calcium influx and seeding,” The Journal of Neuroscience, vol. 27, no. 34, pp. 9220–9232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Clavaguera, T. Bolmont, R. A. Crowther et al., “Transmission and spreading of tauopathy in transgenic mouse brain,” Nature Cell Biology, vol. 11, no. 7, pp. 909–913, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. E. J. Arnoys and J. L. Wang, “Dual localization: proteins in extracellular and intracellular compartments,” Acta Histochemica, vol. 109, no. 2, pp. 89–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. M. N. Le, W. Kim, S. Lee, A. C. McKee, and G. F. Hall, “Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model,” American Journal of Neurodegenerative Disease, vol. 1, no. 3, pp. 316–333, 2012. View at Google Scholar
  69. O. M. El-Agnaf, S. A. Salem, K. E. Paleologou et al., “Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma,” The FASEB Journal, vol. 17, no. 13, pp. 1945–1947, 2003. View at Google Scholar
  70. R. de Silva and M. Farrer, “Tau neurotoxicity without the lesions: a fly challenges a tangled web,” Trends in Neurosciences, vol. 25, no. 7, pp. 327–329, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. N. M. Sherer and W. Mothes, “Cytonemes and tunneling nanotubules in cell-cell communication and viral pathogenesis,” Trends in Cell Biology, vol. 18, no. 9, pp. 414–420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Aguzzi and L. Rajendran, “The transcellular spread of cytosolic amyloids, prions, and prionoids,” Neuron, vol. 64, no. 6, pp. 783–790, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. J. A. Steiner, E. Angot, and P. Brundin, “A deadly spread: cellular mechanisms of α-synuclein transfer,” Cell Death and Differentiation, vol. 18, no. 9, pp. 1425–1433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. I. Devic, H. Hwang, J. S. Edgar et al., “Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease,” Brain, vol. 134, no. 7, article e178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. H. J. Lee, S. Patel, and S. J. Lee, “Intravesicular localization and exocytosis of α-synuclein and its aggregates,” The Journal of Neuroscience, vol. 25, no. 25, pp. 6016–6024, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. H. J. Lee, J. E. Suk, E. J. Bae, J. H. Lee, S. R. Paik, and S. J. Lee, “Assembly-dependent endocytosis and clearance of extracellular α-synuclein,” International Journal of Biochemistry and Cell Biology, vol. 40, no. 9, pp. 1835–1849, 2008. View at Publisher · View at Google Scholar · View at Scopus